Ana Lucrecia Woodward

Array ( [id] => 5895477 [patent_doc_number] => 20060004016 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'Enantiomerically pure opioid diarylmethylpiperazine as a cardioprotection agent' [patent_app_type] => utility [patent_app_number] => 11/187755 [patent_app_country] => US [patent_app_date] => 2005-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8373 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20060004016.pdf [firstpage_image] =>[orig_patent_app_number] => 11187755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4524171 [patent_doc_number] => 07951807 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-31 [patent_title] => 'Substituted oxindol derivatives and medicaments containing the same' [patent_app_type] => utility [patent_app_number] => 11/632462 [patent_app_country] => US [patent_app_date] => 2005-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38137 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/951/07951807.pdf [firstpage_image] =>[orig_patent_app_number] => 11632462 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 151909 [patent_doc_number] => 07678800 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-16 [patent_title] => '2-(1H-indolylsulfanyl)-aryl amine derivatives for use in the treatment of affective disorders, pain, ADHD and stress urinary incontinence' [patent_app_type] => utility [patent_app_number] => 11/629043 [patent_app_country] => US [patent_app_date] => 2005-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15752 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/678/07678800.pdf [firstpage_image] =>[orig_patent_app_number] => 11629043 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5211036 [patent_doc_number] => 20070249620 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-25 [patent_title] => 'Urea Derivative' [patent_app_type] => utility [patent_app_number] => 11/631179 [patent_app_country] => US [patent_app_date] => 2005-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 195532 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20070249620.pdf [firstpage_image] =>[orig_patent_app_number] => 11631179 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4670654 [patent_doc_number] => 20080045714 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-21 [patent_title] => 'Method for Producing Cyclic Diamine Derivative' [patent_app_type] => utility [patent_app_number] => 11/631397 [patent_app_country] => US [patent_app_date] => 2005-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6402 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20080045714.pdf [firstpage_image] =>[orig_patent_app_number] => 11631397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6926532 [patent_doc_number] => 20050239789 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-27 [patent_title] => 'Anti-obesity 1,2,3,4,10,10a-hexahydropyrazino[1,2-a] indoles' [patent_app_type] => utility [patent_app_number] => 11/169079 [patent_app_country] => US [patent_app_date] => 2005-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37758 [patent_no_of_claims] => 118 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20050239789.pdf [firstpage_image] =>[orig_patent_app_number] => 11169079 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 663361 [patent_doc_number] => 07101887 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-09-05 [patent_title] => '1-phenyl-4-benzylpiperazines dopamine receptor subtype specific ligands' [patent_app_type] => utility [patent_app_number] => 11/167735 [patent_app_country] => US [patent_app_date] => 2005-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3673 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/101/07101887.pdf [firstpage_image] =>[orig_patent_app_number] => 11167735 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5821108 [patent_doc_number] => 20060025421 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'Pyridyl piperazines for the treatment of CNS disorders' [patent_app_type] => utility [patent_app_number] => 11/166519 [patent_app_country] => US [patent_app_date] => 2005-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16340 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20060025421.pdf [firstpage_image] =>[orig_patent_app_number] => 11166519 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5101900 [patent_doc_number] => 20070185162 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-09 [patent_title] => 'Substituted diketopiperazines as oxytocin receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/630100 [patent_app_country] => US [patent_app_date] => 2005-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9953 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20070185162.pdf [firstpage_image] =>[orig_patent_app_number] => 11630100 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 285535 [patent_doc_number] => 07550462 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-23 [patent_title] => 'Piperazinediones as oxytocin receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/630179 [patent_app_country] => US [patent_app_date] => 2005-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8120 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/550/07550462.pdf [firstpage_image] =>[orig_patent_app_number] => 11630179 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5739065 [patent_doc_number] => 20060009456 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-12 [patent_title] => 'Aryl-substituted piperazine derivatives' [patent_app_type] => utility [patent_app_number] => 11/154986 [patent_app_country] => US [patent_app_date] => 2005-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 74115 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20060009456.pdf [firstpage_image] =>[orig_patent_app_number] => 11154986 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 54118 [patent_doc_number] => 07767674 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-03 [patent_title] => 'Kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/569809 [patent_app_country] => US [patent_app_date] => 2005-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20795 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/767/07767674.pdf [firstpage_image] =>[orig_patent_app_number] => 11569809 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5211039 [patent_doc_number] => 20070249623 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-25 [patent_title] => '1-(Indole-6-Carbonyl-D-Phenylglycinyl)-4-(1-Methylpiperidin-4-Yl)Piperazine D-Tartrate' [patent_app_type] => utility [patent_app_number] => 11/570686 [patent_app_country] => US [patent_app_date] => 2005-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2862 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20070249623.pdf [firstpage_image] =>[orig_patent_app_number] => 11570686 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6952896 [patent_doc_number] => 20050227991 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-13 [patent_title] => 'New heterocyclic or benzenic derivatives of lipoic acid, their preparation and their use as medicaments' [patent_app_type] => utility [patent_app_number] => 11/147561 [patent_app_country] => US [patent_app_date] => 2005-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12796 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20050227991.pdf [firstpage_image] =>[orig_patent_app_number] => 11147561 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 443352 [patent_doc_number] => 07256289 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-08-14 [patent_title] => 'Process for making chiral 1,4-disubstituted piperazines' [patent_app_type] => utility [patent_app_number] => 11/147055 [patent_app_country] => US [patent_app_date] => 2005-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3933 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/256/07256289.pdf [firstpage_image] =>[orig_patent_app_number] => 11147055 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5374783 [patent_doc_number] => 20090312344 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'ARYLPIPERAZINE DERIVATIVES AS ADRENERGIC RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 11/569838 [patent_app_country] => US [patent_app_date] => 2005-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30966 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20090312344.pdf [firstpage_image] =>[orig_patent_app_number] => 11569838 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 247106 [patent_doc_number] => 07585858 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-08 [patent_title] => 'N-sulfonylcarboximidamide apoptosis promoters' [patent_app_type] => utility [patent_app_number] => 11/138717 [patent_app_country] => US [patent_app_date] => 2005-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19216 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/585/07585858.pdf [firstpage_image] =>[orig_patent_app_number] => 11138717 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6978586 [patent_doc_number] => 20050288304 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-29 [patent_title] => 'Tetrahydronaphthylpiperazines as 5HT1B antagonists, inverse agonists and partial agonists' [patent_app_type] => utility [patent_app_number] => 11/135215 [patent_app_country] => US [patent_app_date] => 2005-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20550 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0288/20050288304.pdf [firstpage_image] =>[orig_patent_app_number] => 11135215 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7740641 [patent_doc_number] => 08106044 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-31 [patent_title] => '8-{4-[3-(5-fluoro-1H-indol-3-yl)-propyl]-piperazin-1-yl}-2-methyl-4H-benzo[1,4]oxazin-3-one mesylate with high affinity for the dopamine D2 receptor and the serotonin reuptake site' [patent_app_type] => utility [patent_app_number] => 11/134455 [patent_app_country] => US [patent_app_date] => 2005-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 815 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/106/08106044.pdf [firstpage_image] =>[orig_patent_app_number] => 11134455 [rel_patent_id] =>[rel_patent_doc_number] =>)